2022
DOI: 10.1155/2022/5699892
|View full text |Cite
|
Sign up to set email alerts
|

ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer

Abstract: ADGRD1 (GPR133), an adhesion G protein-coupled receptor (GPCR), has been linked to cancer. However, the prognostic value and regulatory function within non-small-cell lung cancer (NSCLC) is still unclear. This work adopted various bioinformatics methods, including publicly available databases as well as real-time PCR (RT-PCR), for detecting ADGRD1 expression level and investigating the correlation between ADGRD1 expression level and prognosis, tumor mutational burden (TMB), microsatellite instability (MSI), im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…Similarly, approximately 815,000 new cases and 715,000 new deaths of lung cancer are reported in China recently [ 2 ]. As the most common subtype, non-small cell lung cancer (NSCLC) accounts for approximately 85% in lung cancer [ 3 ]. Currently, there are around 693,000 new cases and 608,000 new deaths of NSCLC in China.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, approximately 815,000 new cases and 715,000 new deaths of lung cancer are reported in China recently [ 2 ]. As the most common subtype, non-small cell lung cancer (NSCLC) accounts for approximately 85% in lung cancer [ 3 ]. Currently, there are around 693,000 new cases and 608,000 new deaths of NSCLC in China.…”
Section: Introductionmentioning
confidence: 99%